Skip navigation |

Laboratory reports of hepatitis C infection in England and Wales - third and fourth quarters 2008

A total of 2325 cases of hepatitis C infection were reported to HPA/CfI in the third quarter of 2008 (table 3). The majority of reports (60%, 1376/2301) were, as in previous quarters, amongst those aged 25-44 years. The ratio of males to females was 2.3:1.

Table 3. Laboratory reports of hepatitis C infection in England and Wales:
July to September 2008

Age group

Male

Female

Unknown

Total

1-4 years

1

3

4

5-9 years

1

1

2

10-14 years

5

2

7

15-24 years

71

70

6

147

25-34 years

424

208

36

668

35-44 years

505

182

21

708

45-54 years

347

124

23

494

55-64 years

118

45

4

167

≥65 years

56

41

7

104

Unknown

11

4

9

24

Total

1539

680

106

2325

In quarter 4, a total of 2027 cases of hepatitis C infection were reported, slightly lower that the 2325 cases reported in the third quarter of 2008 (table 4). The majority of reports (62%, 1246/2015) were, as in previous quarters, amongst those aged 25-44 years. The ratio of males to females is 2.1:1.

Table 4. Laboratory reports of hepatitis C infection in England and Wales:
October to December 2008

Age group

Male

Female

Unknown

Total

1-4 years

1

1

5-9 years

2

2

10-14 years

1

1

15-24 years

67

67

4

138

25-34 years

395

200

29

624

35-44 years

440

157

25

622

45-54 years

256

105

20

381

55-64 years

106

43

11

160

≥65 years

44

38

4

86

Unknown

8

3

1

12

Total

1319

614

94

2027

Quarterly report from the sentinel surveillance study of hepatitis testing in England: data for October to December 2008 (quarter 4)

The sentinel surveillance study of hepatitis testing, which began in 2002, aims to supplement routine surveillance of hepatitis A, B and C infections in England by providing information on trends in testing, individual risk exposures and clinical symptoms. The study collects information on hepatitis A, B and C testing carried out in participating centres regardless of test result and therefore can also be used to estimate prevalence in those individuals tested.

During the last quarter of 2008, a total of 41894 individuals were tested at least once for hepatitis C-specific antibodies (anti-HCV) in 20 participating sentinel centres (table 6). This is the first time these individuals had been reported to the sentinel surveillance scheme.

Overall, 3.9% of individuals tested for anti-HCV were positive, though this varied by region with the highest proportion of positive tests in the North West (table 6). This may reflect more targeted testing of risk groups and/or genuinely higher prevalence in people being tested in this region.

It is important to note that no laboratory methods are currently available to distinguish between acute or chronic hepatitis C virus infections. These positive anti-HCV results do not therefore necessarily represent incident infections.

Table 6. Number of individuals tested, and testing positive, for anti-HCV in participating centres, October – December 2008

Region (number of centres)

Number tested

Number positive (%)

East Midlands (1)

3793

122 (3.2)

East of England (1)

1924

55 (2.9)

London (5)

12821

497 (3.9)

North East (1)

425

20 (4.7)

North West (6)

8106

455 (5.6)

South Central (1)

1065

8 (0.8)

South East Coast (1)

3658

62 (1.7)

South West (1)

4209

186 (4.4)

Wales*

21

1 (4.8)

West Midlands (1)

1536

31 (2.0)

Yorkshire and Humberside (2)

4336

200 (4.6)

Total, all regions (20)

41894

1637 (3.9)

Gender was reported for the majority of people tested. As in previous quarters, similar numbers of males and females were tested (table 7); the ratio of males to females tested was 1.1:1. The ratio of males to females testing positive was 2:1. The largest group tested were aged 25-34 years (n=10768). The percentage of individuals overall testing positive was highest among 45-54 year olds (6.6%). The high level of individuals with unknown age testing positive (5.3%) may reflect testing of individuals in settings such as prisons, drug services and GUM clinics where few demographic details on patients were available and where service users may be at high risk of hepatitis C infection.

Table 7. Age and sex of individuals tested for anti-HCV in participating centres, October – December 2008

Age group

Female

Male

Unknown

Total

Number tested

Number positive (%)

Number tested

Number positive (%)

Number tested

Number positive (%)

Number tested

Number positive (%)

1-14

279

2 (0.7)

268

3 (1.1)

5

552

5 (0.9)

15-24

4550

48 (1.1)

3693

36 (1.0)

166

8409

84 (1.0)

25-34

5043

174 (3.5)

5569

272 (4.9)

156

5 (3.2)

10768

451 (4.2)

35-44

3784

156 (4.1)

5233

397 (7.6)

111

6 (5.4)

9128

559 (6.1)

45-54

2122

86 (4.1)

2963

250 (8.4)

55

2 (3.6)

5140

338 (6.6)

55-64

1565

44 (2.8)

1951

87 (4.5)

29

1 (3.4)

3545

132 (3.7)

≥65

1926

22 (1.1)

2308

39 (1.7)

24

2 (8.3)

4258

63 (1.5)

Unknown

23

1 (4.3)

34

4 (11.8)

37

94

5 (5.3)

Total, all age groups

19292

533 (2.8)

22019

1088 (4.9)

583

16 (2.7)

41894

1637 (3.9)

To provide an indication of trends in testing, data from the 18 sentinel centres from which full data were available were compared for the fourth quarters of 2007 and 2008. In the period October to December 2008, 1355 of 34844 (3.9%) people tested were positive for anti-HCV, compared to 1462 of 30436 (4.8%) for the same period in 2007. This suggests a greater proportion of people at lower risk of infection were tested during the last quarter of 2008.

References1 Health Protection Agency. Quarterly report from the sentinel surveillance study of hepatitis testing in England: data for July to September 2008 (quarter 3). Health Protection Report [serial online] 2006; 3(4): immunisation. Available at: http://www.hpa.org.uk/hpr/archives/2009/hpr0409.pdf